Aemetis Inc. buy krebskrebs
Start price
25.01.21
/
50%
€4.10
Target price
25.01.22
€4.50
Performance (%)
101.22%
End price
26.01.22
€8.25
Summary
This prediction ended on 26.01.22 with a price of €8.25. The BUY prediction by krebskrebs for Aemetis Inc. saw massive gains of 101.22%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aemetis Inc. | -8.268% | -8.268% | -45.047% | -78.121% |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % | 52,05 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % | 84,79 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % | 69,71 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % | 69,52 % |
Comments by krebskrebs for this prediction
In the thread Aemetis Inc. diskutieren
In the thread Trading Aemetis Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten